Energy Drink-Induced Breakthrough Seizure in a Patient on Valproic Acid—Considering Herbal Safety in Epilepsy

Black LI Clarke TC Barnes PM , et al. Use of Complementary Health Approaches Among Children Aged 4–17 Years in the United States: National Health Interview Survey, 2007–2012. National Health Statistics Reports; No 78. Hyattsville, MD: National Center for Health Statistics; 2015.

Clarke TC Black LI Stussman BJ , et al. Trends in the Use of Complementary Health Approaches Among Adults: United States, 2002–2012. National Health Statistics Reports; No 79. Hyattsville, MD: National Center for Health Statistics; 2015.

Guo CY Ronen GM Atkinson SA . Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy. Epilepsia. 2001;42(9):1141–1147.

Mora-Rodriguez R Pallarés JG . Performance outcomes and unwanted side effects associated with energy drinks. Nutr Rev. 2014;72(suppl 1):108–120.

Sorbera M Joseph T DiGregorio RV . Elevated international normalized ratio in a patient taking warfarin and mauby: a case report. J Pharm Pract. 2017;30(5):567–570.

Zaccara G Messori A Moroni F . Clinical pharmacokinetics of valproic acid—1988. Clin Pharmacokinet. 1988;15(6):367–389.

Horn JR Hansten PD Chan LN . Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother. 2007;41(4):674–680.

Natural Medicines. Professional monograph Somerville, MA. 2015. https://naturalmedicines.therapeuticresearch.com/. Accessed August 10, 2015.

Sucher NJ Carles MC . A pharmacological basis of herbal medicines for epilepsy. Epilepsy Behav. 2015;52(pt B):308–318.

Shim CK Cheon EP Kang KW , et al. Inhibition effect of flavonoids on monocarboxylate transporter 1 (MCT1) in caco-2 cells. J Pharm Pharmacol. 2007;59(11):1515–1519.